尿基质金属蛋白酶7水平与狼疮肾炎肾脏发作的关联
这项前瞻性两阶段队列研究在154例新诊断狼疮肾炎患者中评估了活检时尿MMP-7水平与肾脏组织学活性的相关性,并对65例长期缓解患者每两月监测尿MMP-7共2年;发现尿MMP-7升高与组织学活性及肾脏发作风险独立相关,可提前于常规实验室指标提示发作风险。
要点
- 尿MMP-7水平在狼疮肾炎患者中升高,且与肾脏组织学活性指数更高相关。
- 尿MMP-7识别组织学活性指数≥7的效能优于其他临床标志物并提升预测性能。
- 长期缓解后随访中尿MMP-7升高独立关联狼疮肾炎发作风险增加。
核心结论
- 狼疮肾炎患者尿MMP-7水平与肾脏组织学活性相关,长期缓解后尿MMP-7升高与肾脏发作风险增加独立相关。
研究设计与样本
- 前瞻性两阶段队列研究,在2个独立队列的154例新诊断狼疮肾炎患者中评估活检时尿MMP-7水平与肾脏组织学活性的相关性。
- 对65例肾脏疾病缓解至少12个月的患者每两月监测尿MMP-7共2年,分析其与狼疮肾炎发作的关联。
主要发现
- 狼疮肾炎患者尿MMP-7水平升高,更高的尿MMP-7水平与更强的肾脏组织学活性相关。
- 尿MMP-7识别组织学活性指数≥7的狼疮肾炎患者时优于其他临床标志物并改善其预测性能。
- 长期缓解后随访中尿MMP-7升高独立关联狼疮肾炎发作风险增加,且可早于常规实验室指标提示发作风险。
- 尿MMP-7与其他临床指标联合可改善对狼疮肾炎发作的预后预测价值。
关键数值与推荐
- 肾脏组织学活性指数≥7被用作识别更严重肾脏组织学活性的阈值。
- 随访监测在肾脏疾病缓解至少12个月后开始,每两月检测尿MMP-7共2年。
临床怎么用
- 在狼疮肾炎长期缓解患者中可考虑每两月监测尿MMP-7,以早期提示肾脏发作风险。
- 尿MMP-7可与常规临床指标联合用于狼疮肾炎肾脏发作的风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Flares of lupus nephritis (LN) are frequent and associated with impaired renal prognosis. One major management obstacle in LN flare is the lack of effective methods to identify at-risk patients earlier in their disease course. This study was undertaken to test the utility of measurement of urinary matrix metalloproteinase 7 (MMP-7) for the dynamic surveillance of renal disease activity and prediction of renal flares in LN. METHODS: A prospective, 2-stage cohort study was performed in patients with LN. Urinary MMP-7 levels at the time of biopsy were evaluated in 154 patients with newly diagnosed LN in 2 independent cohorts. Urinary MMP-7 levels were assessed for correlation with renal histologic activity. Furthermore, after a minimum period of 12 months of renal disease remission, urinary MMP-7 levels were monitored bimonthly for 2 years in 65 patients with LN. The association between urinary MMP-7 levels and development of LN flare was analyzed. RESULTS: Urinary MMP-7 levels were elevated in patients with LN. A higher urinary MMP-7 level in LN was associated with greater renal histologic activity. As a marker for identifying LN patients with more severe renal histologic activity (i.e., a histologic activity index of ≥7), the level of urinary MMP-7 outperformed other clinical markers and improved their predictive performance, thus linking urinary MMP-7 levels to renal disease activity. Furthermore, among patients who had follow-up measurements of urinary MMP-7 after achievement of long-term remission of renal disease activity, an elevated urinary MMP-7 level during follow-up was independently associated with an increased risk of LN flare. This elevation in the urinary MMP-7 level hinted at the risk of an LN flare at an earlier time point prior to indications using conventional laboratory measures. Thus, use of the urinary MMP-7 level in conjunction with other clinical measures improved the prognostic value for prediction of an LN flare. CONCLUSION: Urinary MMP-7 levels in LN are correlated with renal histologic activity. An elevated urinary MMP-7 level detected after achievement of long-term renal disease remission is associated with a higher risk of incident renal flare in patients with LN.
引用
- Wang G, Wu L, Su H, et al. Association of Urinary Matrix Metalloproteinase 7 Levels With Incident Renal Flare in Lupus Nephritis. Arthritis Rheumatol. 2021. PMID: 32892475. doi:10.1002/art.41506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。